NCT06929260 2026-01-22
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
AstraZeneca
Phase 1 Terminated
Clinical Trials
1 trialsTerminated × Advanced Solid Tumours × factor IX, factor VII, factor X, prothrombin drug combination × Clear all